Klinische Studie

SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)

NCT: NCT07712666 · NOT_YET_RECRUITING

NCT-IDNCT07712666

Medizinische Daten: StatusNOT_YET_RECRUITING

Startdatum2026-11-01

Abschluss2029-08-01

SponsorMayo Clinic (OTHER)

First posted2026-07-17

Last updated2026-09-11

Kurzzusammenfassung

The investigator hypothesizes intraoperative salvaged red blood cells are a poor substitute for allogenic packed red blood cell transfusions. In addition to providing inadequate resuscitation, salvaged red blood cells can increase the rate of complications, including postoperative electrolyte abnormalities, thrombocytopenia, anemia, and coagulopathy.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.